NCT00600847View on ClinicalTrials.gov

A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2007

Conditions
Acquired Cold Urticaria
Interventions
DRUG

desloratadine

single dose for 7 days, oral, 20mg

DRUG

desloratadine

single dose for 7 days, oral, 5 mg

DRUG

placebo

single dose for 7 days, oral

Trial Locations (1)

10117

Allergie-Centrum-Charité Berlin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT00600847 - A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions | Biotech Hunter | Biotech Hunter